Most lately, it has been determined that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to the wide array of endogenous opioids. Not like most opioid receptors, this receptor acts being a scavenger https://epictetusy734ihb8.blogoscience.com/profile